The report published today focuses on the status of current, emerging and potential technologies in TB diagnosis. Many countries still rely on tools such as sputum-smear microscopy but new diagnostics are slowly changing the TB diagnostics landscape. Tuberculosis (TB) continues to be a major public health ...

Ahead of next week’s International AIDS Society Conference on HIV Science in Paris, France, the Global Fund to Fight AIDS, Tuberculosis and Malaria today announced new results that highlight accelerating progress in providing HIV prevention, treatment and care services. The results show that 11 million people are receiving ...

Following the CCM TB/AIDS extraordinary meeting held on June 29, 2017 and the decisions adopted during the meeting, a group of 6 NGOs, CCM members, initiated an active campaign of: 1) contesting the CCM procedures, 3) unilateral misinformation of public opinion, the donor (GF), the development partners, and ...

This year i-Base has produced the HIV pipeline review as part of our Fit for Purpose report on HIV treatment optimisation. Two versions of the HIV pipeline are available: The full version reports key research in detail for each drug. Read the full pipeline report online. The new ...

Health ministers from the BRICS countries (Brazil, the Russian Federation, India, China and South Africa) have agreed to strengthen their surveillance capacity and health-care services to respond to infectious diseases, such HIV, tuberculosis and malaria. They adopted a joint communiqué during the opening ceremony of the ...

A new joint platform for parallel consultation will provide advice to medicine developers and facilitate access to medicines for patients The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) are stepping up their efforts to provide developers of medicines with simultaneous, coordinated advice ...

This publication explains some of the ideas and science behind HIV and treatment.  Each section includes a picture and summary notes. Additional text in each section tells a more detailed story. The resource was developed as an advocacy course for HIV positive people. Nearly everyone who is HIV positive has ...

Individuals and organizations interested in signing on to a civil society version of the Moscow Declaration that could serve as a blueprint for commitments and action toward ending the global impacts of tuberculosis over the next decade and a half have one more day to ...

At its June meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Atripla – Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan (efavirenz/emtricitabine/tenofovir disoproxil) for the treatment of HIV infection. Summary of opinion for Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan is available here. [gview ...

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir. Earlier this month, the World Health Organization (WHO) updated their list of medicines deemed ‘essential’ as part of a well-functioning health system. That is, the drugs ...

Indian scientists from the University of Delhi have identified molecules that could effectively inhibit TB virus and have published all the results of the study in Scientific Reports journal. The molecules are targeting a gene, important for  the bacterium’s survival. Possibly they may find a new ...

Today we begin the launch of “Ten years in public health 2007-2017” – a report that chronicles the evolution of global public health over the decade that I have served as Director-General at WHO. This series of chapters, which will be published over the next 6 ...

6 JUNE 2017 | GENEVA - New advice on which antibiotics to use for common infections and which to preserve for the most serious circumstances is among the additions to the WHO Model list of essential medicines for 2017. Other additions include medicines for HIV, ...

The Medicines Patent Pool (MPP) released a short film, in which MPP’s stakeholders from industry, government, civil society and patient groups discuss the foundation’s innovative business model, achievements and future plans to increase access to HIV, hepatitis C and TB treatment within the context of ...

Launch of the Report of the High-Level Working Group on the Health and Human Rights of Women, Children and Adolescents At a high-level side event, the Report of the High-Level Working Group on the Health and Human Rights of Women, Children and Adolescents was officially handed ...

Several anecdotal reports of mouth ulcers have recently been reported in people switching to generic abacavir in the UK. This should highlight awareness of the potential of likely-rare new side effects, even when both formulations have been approved as bioequivalent. These are likely to be very uncommon reactions, ...

Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed publicly. In a joint statement, the Indian Council of Medical Research, ...

The European Medicines Agency’s (EMA) 2016 annual report published today focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and the safety monitoring of medicines in real life. In 2016, the Agency recommended ...